InsidersTradesSigma
Explore the complete record of transactions filed by McKenna Mark C., Chief Executive Officer. Insider active across 1 company, notably Prometheus Biosciences, Inc.. Aggregated, 2 filings have been recorded. History available since 1 December 2021. The latest transaction was filed on 1 December 2021 (Levée d'options). Regulator: SEC (Form 4). The full history is accessible without signup.
2 of 2 declarations
Mark C. McKenna is the Chief Executive Officer at Prometheus Biosciences, Inc. He oversees the company's operations and is responsible for implementing the overall strategy. His leadership is crucial for the company's success.